Omni Pet Ltd Secures £8m in Latest Funding Round Amid Surging Demand for Plant-Based Pet Food

Omni Pet Ltd, a London-based company specialising in plant-based, allergy-friendly dog food, treats, and supplements, has successfully secured £8m in its latest funding round. The filing for this significant investment was made on 29 April 2026, with the allotment date recorded as 23 December 2025. This substantial capital injection underscores growing investor confidence in the sustainable pet food market and Omni Pet's position within it.

Founded on 16 November 2020, Omni Pet Ltd addresses a critical need for healthier and more sustainable dietary options for dogs. The company's mission is to offer an alternative to traditional pet food, which often relies on animal by-products from the meat industry, contributing to environmental concerns. By providing delicious, plant-based alternatives, Omni Pet caters to pet owners who are increasingly seeking ethical, environmentally conscious, and allergy-friendly choices for their canine companions. The company's LinkedIn profile highlights its specialisation in sustainable pet food, aiming to disrupt the conventional market with its innovative approach. Omni Pet currently employs 32 individuals, according to its latest accounts.

This £8m funding round marks a significant milestone for Omni Pet Ltd, representing its largest single capital raise to date. While a specific valuation for this round has not been disclosed, the investment demonstrates a strong upward trajectory for the company compared to its previous funding activities. Omni Pet has consistently attracted investment since its inception, reflecting steady growth and market traction.

Previous funding rounds include: - £150k raised on 11 September 2021, at a valuation of £3.6m. - £90k raised on 25 March 2024, at a valuation of £8m. - £1.3m raised on 7 August 2024, at a valuation of £9.2m. - £1.1m raised on 1 December 2024, at a valuation of £10.3m. - Two rounds of £131.8k each on 30 January 2025, at valuations of £10m and £9.9m respectively. - A £38.4k round on 3 November 2025, at a valuation of £2.3m.

The latest £8m round, with an allotment date of 23 December 2025, coincides with the appointment of Alex Valente Petri as a director on the same date. AI analysis suggests Alex Valente Petri may be an Investment Director at IW Capital.

The investment in Omni Pet Ltd aligns with a broader trend of increasing interest and funding in the UK's plant-based pet food and pet tech sectors. The UK vegan pet food market was valued at USD 31.54 million in 2024 and is projected to grow to USD 40.56 million by 2030, demonstrating a compound annual growth rate (CAGR) of 4.28% during this period. More broadly, the UK plant-based pet food market is poised for substantial expansion, expected to reach a value of USD 1,163.6 million in 2025 and further grow at a CAGR of 9.7% to hit USD 2,945.6 million by 2035.

This growth is primarily fuelled by a cultural shift towards ethical consumerism, heightened environmental responsibility, and health-conscious lifestyles among pet owners. Consumers are increasingly seeking sustainable and nutritious alternatives to traditional meat-based pet foods, mirroring human dietary trends. The convenience of online retail is also a significant driver, with a growing number of pet owners preferring to purchase pet food online, including niche vegan brands. Furthermore, there is a rising demand for functional vegan pet food products designed to offer specific health benefits beyond basic nutrition.

The overall UK pet care sector is robust, valued at over £6 billion, with the pet food segment alone contributing several billion pounds and projected for continued significant growth. Investment in the wider Pet Tech sector in the UK and Ireland saw a substantial 238.2% rise in funding in 2025 compared to 2024, with £86.3m raised in equity funding across five rounds in 2025. This indicates a healthy appetite among investors for innovative companies addressing the evolving needs of pet owners. Omni Pet Ltd's successful funding round positions it well within this expanding and dynamic market.